Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Change in Acquisitions & Divestments (2019 - 2026)

C4 Therapeutics has reported Change in Acquisitions & Divestments over the past 7 years, most recently at $57.0 million for Q1 2026.

  • For Q1 2026, Change in Acquisitions & Divestments rose 4.13% year-over-year to $57.0 million; the TTM value through Mar 2026 reached $221.3 million, down 5.26%, while the annual FY2025 figure was $219.1 million, 6.07% down from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 was $57.0 million at C4 Therapeutics, up from $52.3 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $90.3 million in Q3 2023 and troughed at $51.2 million in Q3 2025.
  • A 5-year average of $63.7 million and a median of $64.2 million in 2023 define the central range for Change in Acquisitions & Divestments.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 44.85% in 2022 and fell as far as 37.05% in 2022.
  • Year by year, Change in Acquisitions & Divestments stood at $67.1 million in 2022, then increased by 4.35% to $70.0 million in 2023, then fell by 22.19% to $54.4 million in 2024, then fell by 3.86% to $52.3 million in 2025, then grew by 8.94% to $57.0 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for CCCC at $57.0 million in Q1 2026, $52.3 million in Q4 2025, and $51.2 million in Q3 2025.